The Campaign for Affordable Trastuzumab was launched in November 2012 and has been endorsed by over 200 Indian and global patient associations, cancer survivors, health movements, women’s rights activists and eminent jurists.

Kalyani Menon-Sen, Leena Menghaney and KM Gopakumar from this campaign express serious concerns about  the intent and purpose of the “Innovation Dialog” being organised in India from November 16-22, 2014 by the Intellectual Property Owners Association (IPOA).

To: Hon’ble Justice Mr. H.L. Dattu (Hon’ble Chief Justice of India); Hon’ble Justice Smt. G. Rohini, (Chief Justice, Delhi High Court); Hon’ble Justice K.N. Basha (Chair, Intellectual Property Appellate Board)

Dear Hon’ble Justice Dattu, Hon’ble Justice Rohini and Hon’ble Justice K.N. Basha,

We write to you on behalf of the Campaign for Affordable Trastuzumab, a network of treatment activists, patients and public interest lawyers committed to making the breast cancer drug – trastuzumab – affordable in India. We have closely followed the misuse of patent rights and more recently the vexatious litigation of the Swiss pharmaceutical company Hoffmann-La Roche Ltd in India to maintain control over the market for the life–saving drug (trastuzumab), thus blocking access to treatment for thousands of women with HER2+ breast cancer.

This letter is to express our grave concern about the intent and purpose of the “Innovation Dialog” being organised in India from November 16-22, 2014 by the Intellectual Property Owners Association (IPOA).

The IPOA is a US-based group consisting of large corporations and law firms which has been aggressively lobbying on issues of intellectual property standards and enforcement in India and pushing a pro-corporate agenda. The biased and unbalanced position taken by the IPOA is especially troubling when it concerns medicines, where the use of intellectual property protections have restricted access to affordable treatment and blocked competition.
Continue reading Concerns on proposed meetings of Intellectual Property Owners Association with IPAB and the Delhi High Court: Campaign for Affordable Trastuzumab →